InvestorsHub Logo
Followers 155
Posts 2642
Boards Moderated 0
Alias Born 01/29/2004

Re: kevindenver post# 441775

Wednesday, 12/06/2023 2:33:51 PM

Wednesday, December 06, 2023 2:33:51 PM

Post# of 462187
“Imagination” will fail. Knowledge will succeed.

Those who don't know how to "imagine" shouldn't be in biotech IMO. It takes a vision to be in it to win it.
There may only be a 10% success rate statistically with biotech....


Imagination has no useful function in trying to determine if a startup biotech firm can ever achieve commercial success. In the case of Anavex Life Sciences Corp, the matter depends upon the therapeutic validity of the company’s unique, proprietary candidate drug molecules.

And the known, demonstrated science of those molecules, in propitiously activating the sigma-1 receptor protein, thereby producing a diversity of “downstream” physiological outcomes which restore or promote a number of healthful cell-keeping processes, is now well-demonstrated in both transgenic murines (lab rodents) with human disease genes, and in humans themselves. There’s nothing imaginary about blarcamesine’s health-restoring mechanisms of action or therapeutic safety.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News